Вы находитесь на странице: 1из 2

For personal use only.

Not to be reproduced without permission of the editor


(permissions@pharmj.org.uk)
The Society

Guidance on recording of interventions


This guidance has been produced in the Practice and Quality Improvement Directorate of the Royal Pharmaceutical Society

his guidance aims to provide pharmacists with advice on the

T recording of any interventions they may make during the course


of their practice. In particular, the guidance offers advice on the
following:

When an intervention is of sufficient significance for it to be


recorded
The content of records made
Where the records should be made
How these records could be used to improve efficiency and safety
across the NHS
How long these records need to be retained

The recording of interventions will be in writing initially but will


become easier once the necessary IT software to support this is more
readily available.
Any local or employers policies on the recording of inter-
ventions should prevail but in the absence of any such policy then
this guidance may be helpful and should be seen as a minimum
requirement.

1. Why record interventions? All sectors should establish robust mecha- 3. What to record
There are four main reasons why pharmacists nisms for sharing information that could be The level of detail necessary for recording
should want to record their interventions: used by other pharmacists to improve the interventions will vary depending on each
overall standard of pharmaceutical care. situation. Pharmacists should aim to keep
To help ensure patient safety and improve the records concise by recording only what
the quality and continuity of patient care 2. When to record interventions is important and excluding any extraneous
To provide evidence to demonstrate the Pharmacists are not required to record every information.
additional value of pharmacist professional intervention they make or to record all the It may be necessary to record some or all
input into a procedure such as dispensing, advice that they give. However, the following of the following details:
over-the-counter sales, etc, and improve- should be considered for recording:
ment in patient care through their clinical Identification of patient or other person
input to prescribing Interventions that are of clinical signifi- involved, where possible, or a brief de-
To have an accurate record available for cance (ie, could be regarded as having a scription of the patient/person
scrutiny where decisions could be chal- direct impact on patient care) Name and address of patient/person, if
lenged, eg, intervention on prescribing Interventions that provide learning oppor- available
quality or accuracy tunities to improve overall standards of NHS number if available
For monitoring incidents or near misses in care Name of regular GP and/or practice or
relation to the prescribing, dispensing or Interventions that could potentially be hospital consultant
administration of medicines as part queried or refuted (so that a record is Medical conditions
of an organisations clinical governance available for future reference) Date of intervention
framework If the patient or patient representative Time of intervention
queried or disagreed with the intervention Name of person who made the interven-
Although this guidance focuses on com- If the intervention affects or impacts on tion or gave the advice
munity pharmacy systems, the recording of another member of the health care team Patient condition or concern
interventions applies wherever a pharmacist referral or refusal of disclosure Summary of intervention including out-
practises. The entry should serve as a record If the intervention relates to an extended comes or proposed courses of action
of the critical thinking and judgement the service that the pharmacist is being paid Names and roles of other people involved
pharmacist has used in assessing the situation for and is contracted to provide in the intervention or contacted
and then go on to describe events and dis- It may also be necessary to record all in- Sources of information used
cussions he or she has had with patients, pa- terventions over fixed periods of time on a
tient representatives or other health and social regular basis (point prevalence studies) to A pharmacist may not always have at hand
care professionals to effect that decision. establish workload trends, or patterns of all the information needed to make a detailed
Recording interventions demonstrates the medication-related problems record. Information recorded should be of as-
degree of responsibility and accountability the sistance should there be a subsequent enquiry
pharmacist has taken for his or her professional Records of interventions should be made regarding the nature of the intervention.
activities and is a key component in demon- as soon as possible after the event has oc- All records made should be well organised
strating how professional judgement is applied. curred. This enables the recording of details and legible, only using clear and established
Records should not be limited to pre- to be more accurate. abbreviations that are common to all health
scription interventions but should include Appendix 1 contains examples of inter- care professionals. These records should not
any situation where a pharmacist makes a sig- ventions that could be recorded in both contain any unfounded opinions or conclu-
nificant contribution to patient care. primary and secondary care. sions and where conclusions are drawn these

www.pjonline.com 29 April 2006 The Pharmaceutical Journal (Vol 276) 517


The Society
should be supported by evidence. All patient reporting/background). Most hospitals will 6. How long should records be kept?
identifiable material should be regarded as have their own incident reporting systems Local or employers policies should be fol-
confidential and be kept securely but be read- that feed into the NPSA. Interventions of lowed but as a matter of good practice:
ily retrievable. Data protection issues and the major clinical significance should be recorded
accessibility of records by patients and their as near misses on the hospital system. Paper records should be kept for seven years
representatives should be considered carefully Scotland does not currently have a national Electronic records should be kept for at
when making any records. system for reporting incidents. least 20 years
Where the intervention involves an ad-
4. Where to record verse reaction to a medicine, consideration 7. Guidance for locums
Ideally, the interventions should be entered should also be given to reporting through the Locum pharmacists should follow guidance
into the PMR where this exists for a patient. Medicines and Healthcare products established within the pharmacy and leave
However, this may not always be possible, in Regulatory Agency/Committee on Safety of records of their interventions in the preferred
which case records could be made in a sep- Medicines yellow card scheme, unless the format.The locum should follow the SOP in
arate book or standardised pro-forma iden- prescriber has already reported it. (See the pharmacy for recording interventions. He
tified for this purpose or an electronic Reporting safety problems in the Safety or she may also wish to make additional
version once this is available. If records are information section of the MHRA website records, which they can use for their own
made in a separate book etc then this should [www.mhra.gov.uk].) CPD and learning purposes.
be cross-referenced on the PMR wherever Locum pharmacists must satisfy them-
possible. 5. How to use these records selves of the confidentiality systems in place
In Scotland, some hospitals use care plan- Reflective learning: this could be within before making such records.
ning as a means of recording care issues. the pharmacy team or as an action learn-
These care issues are often interventions, so ing set or pharmacy development group 8. Important points
this is another method of keeping a record of where specific examples are shared and Records of interventions need to be
interventions made. The exchange of care discussed (To protect confidentiality, auditable
planning information with community phar- patients details must not be included.) Records of interventions should be
macists is being encouraged. Significant events analysis (SEA): can be kept locally, ie, where the prescrip-
Records of interventions should be used within the pharmacy as a learning tion is given out
available in each individual pharmacy to aid tool or as an audit of standards Each pharmacy should have a stan-
continuity of care. National survey or audits dard operating procedure in place,
If the intervention relates to a serious in- Ensure consistency and continuity of stan- outlining where records of inter-
cident then, in England and Wales, this should dards, so that locums can refer to these files ventions should be made, what
be reported to the National Patient Safety to gain an understanding of previous oc- information should be recorded and
Agency via its National Reporting and currences and make their own contribu- when such interventions should be
Learning System ( www.npsa.nhs.uk/health/ tion to the process recorded.

Appendix 1: Examples of interventions that could be recorded in pharmacies


Community pharmacy Records of public health advice given (linked to but just a note to identify that the patients has
The following are examples of interventions prescriptions) undergone a review and the date it occurred.
that could be recorded in community Advice on change of diet (Full records of the review will be available
pharmacies. In most cases, recording the Advice on other lifestyle changes elsewhere in the pharmacy.)
intervention would not be sufficient Smoking cessation
action to protect patient safety may also be Alcohol consumption Hospital pharmacy
required. Weight management The following are examples of interventions
Increased exercise that could be recorded in hospital pharmacies.
Records of prescription interventions Advice on malaria prophylaxis
Major interaction Records of prescription interventions
Dosage or medicine query with patient Records of signposting Clinically significant interactions
and/or prescriber Referral of a patient to a doctor or a Dosage or medicine query with the
Use of medicines outside their licensed hospital for any reason prescriber
indications Referral of a patient to other health care Use of medicines outside their licensed
Prescribed medicine not supplied because professionals or social carer indications
patient does not require it Referral to a doctor following a blood Excessive prescribing
Excessive prescribing pressure, cholesterol or other diagnostic Incidents where there is duplication of
If interaction flagged by the computer test result therapy or where a medicine is no longer
system has been overridden after a clinical required
assessment Records of self-care advice given Significant prescription interventions
Significant prescription interventions Advice on OTC medication only initiating a medication review
initiating a medication review (including where this is of clinical significance, or as Suspected adverse drug reaction
medicines use reviews) part of a minor ailment scheme Suggested changes of treatment for
Incidents where there is duplication of Advice on contraindications (eg, impact improved prescribing
therapy or where a medicine is no longer on ability to drive) Suggestions that a medicine is not
required prescribed
Suspected adverse drug reaction Records of medication reviews Formulary queries
Evidence of non-compliance or non- Pharmacists should make a note on the pa- Therapeutic substitution or deletion by
adherence with therapy tients PMR if they carry out a medication the pharmacist under local protocols
Evidence of any interaction with co- review, such as MUR, for that patient. This Incomplete or incorrect medication his-
prescribed or OTC therapy does not have to be a full record of the review tory, including non-recording of allergies

518 The Pharmaceutical Journal (Vol 276) 29 April 2006 www.pjonline.com

Вам также может понравиться